Scilex Holding Company (SCLX)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
SCLX price, last 12 months
Key stats
- Previous close
- $4.94
- Open
- $5.00
- Day range
- $4.83 – $5.37
- 52-week range
- $4.20 – $30.90
- Volume
- 38.6K
- Avg volume (20 days)
- 30.2K
- Market cap
- $34.4M
Performance
Technicals and fundamentals
About Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $34.4M